Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 23 631,21 Kč, with a 24-hour trading volume of 82,39B Kč. The asset's market cap is 21,07T Kč, after moving 0.55% in the last day.
Tokenized Eli Lilly And Co is trading at 23 731,3 Kč, with a tokenized market cap of 946,52M Kč and a 24-hour trading volume of 59,64M Kč. The tokenized asset has moved -0.12% in the past 24 hours.